S&P 500: 672.38 -1.3% NASDAQ 100: 599.75 -1.5% Dow Jones: 475.23 -1.0%

TransMedics Group, Inc.

TMDX Healthcare
$129.61 $-10.46 (-7.47%)
Market Cap: $4.45 B
Gurus Holding
5
Popularity Rank
#1723
% of Shares Held
0.91%
Net Activity (Q4 2025)
-$14.95 M

Guru Ownership Trend

Guru Analysis for TransMedics Group, Inc. (TMDX)

TransMedics Group, Inc. (TMDX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $40.68 M.

Top institutional holders include Chuck Royce and Joel Greenblatt.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $14.95 M net outflow during the quarter.

Recent activity highlights Joel Greenblatt who increased their stake by 396.2%. Conversely, Renaissance Technologies reduced exposure by 92.9%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$5.76 M
Total Buy Value
New Buys 1
Additions 1
-$20.71 M
Total Sell Value
Reductions 2
Sold Out 2

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
4
Net Buyers
2

FAQs for TransMedics Group, Inc. (TMDX)

Major holders include Chuck Royce ($29.58 M), Joel Greenblatt ($4.97 M), John Hussman ($1.79 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 313,828 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $14.95 M, with 2 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited TMDX. The total reported sell value was $20.71 M.

Yes, 1 managers opened new positions in TMDX, and 1 increased their existing holdings. The total reported buy value was $5.76 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.30% 243,149 $29.58 M Q4 2025
0.02% Add 396.2% 40,872 $4.97 M Q4 2025
0.43% New Buy 14,700 $1.79 M Q4 2025
0.00% Reduce -92.9% 10,299 $1.25 M Q4 2025
0.00% Reduce -44.1% 4,808 $584,894 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form